Semicarbazide sensitive amine oxidase (SSAO) inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Semicarbazide sensitive amine oxidase (SSAO) inhibitor, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH) [Phase 2]